DailyDoctor Archive Specialties Get app
All emergency & critical care briefings

The edition · Emergency & Critical Care

Restricted fluids with early vasopressors matched liberal fluids in septic shock, with less pulmonary oedema; persistent hypoperfusion sharpens the refractory shock definition

A 1,000-patient emergency department trial leads an edition that adds a risk-stratification analysis in refractory shock, a target trial emulation of lidocaine versus amiodarone, and two pulmonary embolism assessment studies.

The edition in brief

In ARISE FLUIDS, 1,000 emergency department patients with septic shock were randomised to restricted fluids with early vasopressors or higher-volume fluids with later vasopressors. Days alive and out of hospital at day 90 were identical (median 76 in both groups; difference 0.0 days, 95% CI -2.7 to 2.7), and pulmonary oedema was less frequent with restricted fluids (0.6% vs 5.0%). A secondary analysis of ANDROMEDA-SHOCK-2 (1,363 patients) found that combining a high vasopressor dose with persistent hypoperfusion (abnormal capillary refill and non-falling lactate) after six hours identified 53 patients with 73.6% 28-day mortality, against 23.7% for the rest (adjusted HR 4.68); the authors call this hypothesis-generating. A target trial emulation of 2,451 out-of-hospital cardiac arrests found no statistically significant survival difference between lidocaine and amiodarone (26.2% vs 23.5%; difference 2.8%, 95% CI -0.6 to 6.2). In 194 patients with pulmonary embolism, emergency physician point-of-care ultrasound was 76.8% sensitive and 85.9% specific for right ventricular dysfunction against consultative echocardiography, and a composite shock score had similar associations to sPESI and ESC classes for short-term outcomes. A pearl on reassessing after each fluid bolus closes the edition.

In this edition
01
Clinical update

Capillary refill plus lactate sharpened the definition of refractory septic shock

After six hours of resuscitation, check capillary refill and lactate as well as vasopressor dose when judging how sick a patient in shock is.

1 min · Intensive care medicineRead →
Primary outcome
28-day mortality by refractory septic shock definition
Effect
73.6% vs 23.7% (adjusted HR 4.68, 95% CI 3.31 to 6.64); positive LR 8.12 vs 2.71 for dose alone
02Research

Lidocaine or amiodarone in shockable arrest: no clear survival difference

No clear survival difference between lidocaine and amiodarone; follow local protocol and avoid delay in either.

1 min · Critical care medicineRead →
03Research

Bedside ultrasound for right ventricular dysfunction in PE: 77% sensitive, 86% specific

Treat a negative bedside ultrasound as incomplete in PE risk stratification and confirm with formal echocardiography when it matters.

1 min · Annals of emergency medicineRead →
04Research

A composite PE shock score performed similarly to sPESI for short-term outcomes

Keep using established PE risk tools; a shock score may help anticipate advanced intervention but needs prospective validation.

1 min · Annals of emergency medicineRead →
05Pearl

Reassess after every fluid bolus

Treat each bolus as a test: reassess perfusion and breathing before the next one.

1 minRead →
06
Practice changer

ARISE FLUIDS: restricted fluids with early vasopressors matched liberal fluids, with less pulmonary oedema

Early vasopressors with restricted fluids are a reasonable alternative to liberal fluids in septic shock where monitoring allows, with less pulmonary oedema.

2 min · The New England journal of medicineRead →
Primary outcome
Days alive and out of hospital to day 90
Effect
Median 76 vs 76 days; difference 0.0 (95% CI -2.7 to 2.7); pulmonary oedema 0.6% vs 5.0%

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for emergency & critical care, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free